Enter assignee name

EPO Patents = 2

Forward Citations = 20

Loading Chart...

6 inventors (with patents filed for the assignee):

Qing Dong (11 out of 67 patents)

Stephen W Kaldor (11 out of 66 patents)

Robert L Hoffman (10 out of 10 patents)

4. Lynnie Lin Trzoss (8 out of 16 patents)

5. Porino Jinjo Va (6 out of 6 patents)

6. Joseph Robert Pinchman (5 out of 26 patents)

11 patents: Sort by Forward Citations

1. 12421241 - Substituted pyridines as PARP1 inhibitors (2025-09-23),

2. 12384780 - PARP1 inhibitors and uses thereof (2025-08-12),

3. 12139462 - Pyridinone MK2 inhibitors and uses thereof (2024-11-12),

4. 12006322 - Substituted pyridines as PARP1 inhibitors (2024-06-11),

5. 11987574 - MK2 inhibitors and uses thereof (2024-05-21),

6. 11939329 - PARP1 inhibitors and uses thereof (2024-03-26),

7. 11802128 - Azetidine and pyrrolidine PARP1 inhibitors and uses thereof (2023-10-31),

8. 11795173 - Substituted pyridines as PARP1 inhibitors (2023-10-24),

9. 11685719 - Pyridinone MK2 inhibitors and uses thereof (2023-06-27),

10. 11680056 - MK2 inhibitors and uses thereof (2023-06-20),

11. 11591331 - PARP1 inhibitors and uses thereof (2023-02-28),

Xinthera, Inc. is a biotechnology company focused on developing innovative therapeutics for the treatment of cancer. Our proprietary technology platform allows us to target and deliver therapies directly to cancer cells, minimizing side effects and improving patient outcomes. With a strong commitment to research and development, Xinthera is dedicated to advancing the field of oncology and improving the lives of cancer patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

11 Patents

#466 in San Diego, CA

#6,343 in California

#26,744 in US

#50,229 in the World

San Diego, CA, United States of America

Xinthera, Inc.